i just read about someone whose telehealth provider cancelled their mounjaro after they mentioned emotional eating and binging. and i’m genuinely confused - isn’t emotional eating kind of the whole reason people end up needing these medications in the first place? i’m four months into zepbound (started 2.5, bumped to 5 recently), adn i’ve been pretty honest about struggling with food postpartum. the sleep deprivation plus hormonal shifts made me someone eating at 3am just to feel something different. but that’s literally why the medication has helped. so i’m wondering: are other telehealth companies screening for this? what’s the actual line between eating patterns this could help with and too severe to safely prescribe? because it feels backwards - flagging the problem as a reason to deny the solution. has anyone else had their provider bring this up, or had it affect their access? genuinely trying to understand the logic here.
Something that hasn’t come up here is the difference between what the clinical contraindication language actually says versus what telehealth platforms are operationalizing. Active eating disorders requiring medical monitoring, specifically where purging or restriction creates instability, are the concern in the prescribing literature. Emotionally-driven overeating, especially the kind you’re describing, postpartum sleep deprivation, hormonal chaos, eating to regulate nervous system state, is not the same category, but some platforms are running broad BED screening tools and flagging anything above a score threshold as liability exposure, full stop. The part that I keep thinking about is your phrase “eating at 3am just to feel something different.” There’s actually emerging research on GLP-1 receptor agonists modulating reward-pathway signaling beyond just satiety, appetite suppression as a downstream effect of something happening in dopamine regulation. If that mechanism is real, people who are eating compulsively for emotional regulation may be exactly the population with the most to gain neurologically, not just metabolically. What you’re describing isn’t a reason to deny the medication. It’s a description of why metabolic dysfunction and stress physiology overlap so much in the first place. Worth asking your prescriber directly how they define the line, because “emotional eating” and “active eating disorder requiring psychiatric stabilization before prescribing” are not the same thing, and the conflation is doing real harm to access.
the “flagging the problem as a reason to deny the solution” framing is exactly the tension worth naming here. telehealth providers pulling prescriptions over emotional eating mentions are probably pattern-matching to an ED screening checklist, not making nuanced clinical calls - the concern is usually active purging or restrict-binge cycles, not postpartum stress eating. the irony is that suppressed reward-driven eating is basically one of the documented mechanisms of glp-1s. you’re describing the thing the drug actually addresses
the dopamine research piece is interesting but feels speculative - you’re connecting “emerging research suggests” to “exactly the population with the most to gain neurologically,” and i don’t think we’re there yet. my prescriber would still be cautious about someone describing compulsive eating patterns regardless of trigger, because that’s just standard clinical practice around eating behaviors. maybe the real issue isn’t platform screening being too broad, but that legitimate clinical caution looks indistinguishable from overreach on the patient side
the “looks indistinguishable from overreach on the patient side” framing lets the platform off the hook a bit too easily. a real intake can distinguish postpartum stress eating from a dx-level BED pattern, the question is whether telehealth scripts actually give anyone the room to make that call.
the distinction most telehealth platforms use is binge eating disorder (clinical) vs. emotional eating (extremely common and arguably what glp-1s directly address neurologically). postpartum sleep deprivation driving 3am eating isn’t a contraindication, it’s basically the case study.
the distinction that actually matters here, and most telehealth platforms seem to mangle it, is between emotional eating as a behavioral pattern and binge eating disorder as a diagnosable condition (it’s in the DSM-5 w/ specific criteria around frequency, loss of control, distress). GLP-1s reducing appetite and food noise can genuinely help the former; the latter typically warrants co-treatment with a therapist or ED specialist, and some guidelines suggest that’s a prerequisite before prescribing. the problem is that when you describe “eating at 3am just to feel something different,” a cautious (or liability-averse) telehealth doc may not know which bucket you’re in, and cancelling is the easiest CYA move. it’s not that the logic is backwards exactly, it’s that the screening is blunt and the nuance is getting lost.
the phrase “too severe to safely prescribe” is doing a lot of work here, and I don’t think it actually tracks clinically. the concern behind those intake screenings is usually active purging behaviours: specifically the worry that GLP-1-induced nausea could be recruited as a compensatory mechanism in a purge cycle, which is a legitimate pharmacological safety question. what you’re describing (3am eating driven by sleep deprivation and postpartum hormonal dysregulation) is a completely different mechanism, and some telehealth intake algorithms seem built to flag the word “binging” without any ability to distinguish stress eating from clinical BED. the additional irony is that tirzepatide and semaglutide are actively being studied for binge eating disorder right now, with small trials and case series showing meaningful symptom reduction in actual BED patients. the “emotional eating = cancel the script” logic is almost precisely backwards to where the research is heading. if you’ve had a formal eating disorder screen and came up negative for purging behaviours, stating that explicitly at your next check-in is probably more useful than leaving it as a general “I struggle with food” disclosure.
my prescriber basically said ‘emotional eating is why you’re here’ and only flags actual ED history, not postpartum eating struggles. so either that person hit a provider with weird gatekeeping or there’s more to the story (prior ED diagnosis?). ask specifically what triggered teh cancellation, that distinction probably matters